
结论很明确:这个市场不适合进入。 现有样本里新品牌入场成功率是0%,所有可见的新上架产品都是失败,市场也没有显示出给新玩家留口子的迹象;对小商家尤其不友好,对大品牌来说也不是值得重金切入的盘子。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是一个适合进入的市场:当前样本里新品牌入场成功率为0%,新旧品牌新上架产品的盈利率都为0%,而且可见的新入场只有 VISDOLL 一家新品牌,却直接失败;同时 BIOESTHE 这个老品牌靠 1 个在售款做到 17.99 美元、月销约100件、月营收1799美元,说明真正能活下来的主要是老品牌的存量款,不是新玩家。 用户预算50万人民币看起来够做单个ASIN的前期起步,但在这个市场里,预算不是关键问题,关键是差异化和品牌势能不足:唯一明显成功的 BIOESTHE ASIN 是 B0F62YV1H3,月营收1799美元、51条评价、4.8分、利润率29.48%;而 VISDOLL 的 B0GRMBKHXH 作为新品牌新上架款直接无销量、无利润,属于失败样本。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,结论很明确:新品牌已出现100%失败,老品牌的新上新也100%失败,且当前能跑出来的只有老品牌的存量款。 这不是适合小品牌试错的市场,也不是大品牌该重金切入的市场;如果没有明显创新、品牌势能和长期烧钱能力,进去大概率就是亏。
这个市场不值得进入:样本里可见的新品牌进入几乎没有正向结果,且竞争更像是靠老品牌和少量强势单品在撑场,新品牌想靠正常打法拿到利润的概率很低。按现有数据看,这不是一个适合小品牌试错的市场,更不是一个值得重仓的大品牌增量市场。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0F62YV1H3 | BIOESTHE | 2025-07-19 | Yes | $17.99 | 100pcs | $1799.0 | 29.48% | $530.35 |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0FN7ZF3HM | BIOESTHE | 2025-08-21 | No | $- | -pcs | $- | -% | $- |
![]() | B0GRMBKHXH | VISDOLL | 2026-03-07 | No | $- | -pcs | $- | -% | $- |
这个市场不值得进入:新品牌切入后几乎没有真实成功案例,整体是低利润、低成功率、强竞争的状态。对大品牌和小商家都不是好市场,原因不是“还能卷”,而是已经被旧品牌和同类产品压到只剩价格与投放竞争。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
这个市场不适合现在进入,结论很明确:新品牌几乎没有跑通,且已经出现明显的失败案例。 目前只看到2个新上架产品,1个来自新品牌VISDOLL、1个来自老品牌BIOESTHE;两者的新上架结果都是失败,等于新发布成功率是0%,不是可进入市场。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |